Tianjin Medical Journal ›› 2023, Vol. 51 ›› Issue (5): 498-503.doi: 10.11958/20221287
• Experimental Research • Previous Articles Next Articles
GENG Yongzhi1(), YANG Li2, LI Guowei1, ZHANG Jintao1, CHENG Xiaolei1, TAN Liduan1,△(
)
Received:
2022-08-18
Revised:
2022-09-28
Published:
2023-05-15
Online:
2023-05-05
Contact:
△E-mail:ceinf60@163.com
GENG Yongzhi, YANG Li, LI Guowei, ZHANG Jintao, CHENG Xiaolei, TAN Liduan. Study on the improvement effect and mechanism of nobiletin on rats with acute kidney injury[J]. Tianjin Medical Journal, 2023, 51(5): 498-503.
CLC Number:
基因名称 | 引物序列(5'→3') | 产物大小(bp) |
---|---|---|
SIRT1 | 上游:CAGTTCCAGCCATCTCTGTG | 158 |
下游:GCAACCTGCTCCAAGGTATC | ||
FOXO3a | 上游:GCAAACCCTCTCGGACTCTC | 116 |
下游:TTCCCCACATTCAAACCAAC | ||
GAPDH | 上游:ACAGCAACAGGGTGGTGGAC | 197 |
下游:TTTGAGGGTGCAGCG AACTT |
Tab.1 The primer sequence for qPCR
基因名称 | 引物序列(5'→3') | 产物大小(bp) |
---|---|---|
SIRT1 | 上游:CAGTTCCAGCCATCTCTGTG | 158 |
下游:GCAACCTGCTCCAAGGTATC | ||
FOXO3a | 上游:GCAAACCCTCTCGGACTCTC | 116 |
下游:TTCCCCACATTCAAACCAAC | ||
GAPDH | 上游:ACAGCAACAGGGTGGTGGAC | 197 |
下游:TTTGAGGGTGCAGCG AACTT |
组别 | 24 h尿微量 白蛋白(mg) | 尿NAG (U/L) | 尿β2-MG (mg/L) |
---|---|---|---|
Control组 | 7.86±2.55 | 1.44±0.18 | 6.54±0.96 |
Model组 | 92.64±12.58a | 4.67±1.25a | 52.42±6.85a |
NOB-L组 | 68.25±9.68b | 3.37±0.59b | 34.66±4.20b |
NOB-H组 | 25.13±3.74bc | 1.95±0.34bc | 21.37±2.46bc |
NOB-H+EX527组 | 56.12±8.26d | 2.89±0.45d | 32.94±2.61d |
F | 265.892** | 60.064** | 295.741** |
Tab.2 Comparison of 24 h urinary microalbumin, urinary NAG and urinary β2-MG levels between the five groups of rats
组别 | 24 h尿微量 白蛋白(mg) | 尿NAG (U/L) | 尿β2-MG (mg/L) |
---|---|---|---|
Control组 | 7.86±2.55 | 1.44±0.18 | 6.54±0.96 |
Model组 | 92.64±12.58a | 4.67±1.25a | 52.42±6.85a |
NOB-L组 | 68.25±9.68b | 3.37±0.59b | 34.66±4.20b |
NOB-H组 | 25.13±3.74bc | 1.95±0.34bc | 21.37±2.46bc |
NOB-H+EX527组 | 56.12±8.26d | 2.89±0.45d | 32.94±2.61d |
F | 265.892** | 60.064** | 295.741** |
组别 | BUN(mmol/L) | Scr(μmol/L) |
---|---|---|
Control组 | 2.58±0.54 | 18.63±2.57 |
Model组 | 8.84±1.46a | 82.51±10.23a |
NOB-L组 | 6.72±1.34b | 60.16±7.44b |
NOB-H组 | 3.89±0.70bc | 42.56±6.30bc |
NOB-H+EX527组 | 5.24±1.25d | 56.27±8.82d |
F | 109.769** | 135.065** |
Tab.3 Comparison of serum BUN and Scr levels between the five groups of rats
组别 | BUN(mmol/L) | Scr(μmol/L) |
---|---|---|
Control组 | 2.58±0.54 | 18.63±2.57 |
Model组 | 8.84±1.46a | 82.51±10.23a |
NOB-L组 | 6.72±1.34b | 60.16±7.44b |
NOB-H组 | 3.89±0.70bc | 42.56±6.30bc |
NOB-H+EX527组 | 5.24±1.25d | 56.27±8.82d |
F | 109.769** | 135.065** |
组别 | SOD (U/mL) | MDA (nmol/L) | SIRT1 | FOXO3a |
---|---|---|---|---|
Control组 | 285.27±35.42 | 2.54±0.68 | 1.00±0.00 | 1.00±0.00 |
Model组 | 140.54±25.49a | 9.10±1.14a | 0.37±0.07a | 0.42±0.03a |
NOB-L组 | 190.65±25.61b | 7.57±0.85b | 0.55±0.06b | 0.60±0.08b |
NOB-H组 | 248.40±33.04bc | 4.38±0.49bc | 0.78±0.04bc | 0.82±0.06bc |
NOB-H+EX527组 | 180.35±27.27d | 6.80±0.77d | 0.62±0.09d | 0.64±0.04d |
F | 36.728** | 113.609** | 159.341** | 289.526** |
Tab.4 Comparison of SOD and MDA contents and expression levels of SIRT1 and FOXO3a mRNA in renal tissue between the five groups of rats
组别 | SOD (U/mL) | MDA (nmol/L) | SIRT1 | FOXO3a |
---|---|---|---|---|
Control组 | 285.27±35.42 | 2.54±0.68 | 1.00±0.00 | 1.00±0.00 |
Model组 | 140.54±25.49a | 9.10±1.14a | 0.37±0.07a | 0.42±0.03a |
NOB-L组 | 190.65±25.61b | 7.57±0.85b | 0.55±0.06b | 0.60±0.08b |
NOB-H组 | 248.40±33.04bc | 4.38±0.49bc | 0.78±0.04bc | 0.82±0.06bc |
NOB-H+EX527组 | 180.35±27.27d | 6.80±0.77d | 0.62±0.09d | 0.64±0.04d |
F | 36.728** | 113.609** | 159.341** | 289.526** |
组别 | SIRT1 | FOXO3a | LC3-Ⅱ/ LC3-Ⅰ | Beclin-1 |
---|---|---|---|---|
Control组 | 0.79±0.04 | 0.86±0.06 | 2.12±0.18 | 0.56±0.04 |
Model组 | 0.25±0.02a | 0.32±0.04a | 0.56±0.06a | 0.10±0.01a |
NOB-L组 | 0.46±0.05b | 0.50±0.02b | 1.08±0.04b | 0.23±0.02b |
NOB-H组 | 0.62±0.03bc | 0.71±0.05bc | 1.83±0.07bc | 0.42±0.02bc |
NOB-H+EX527组 | 0.49±0.03d | 0.53±0.03d | 1.14±0.05d | 0.30±0.02d |
F | 390.386** | 306.840** | 226.787** | 793.818** |
Tab.5 Expression levels of SIRT1/FOXO3a pathway and autophagy-related proteins in kidney tissue of rats in each group
组别 | SIRT1 | FOXO3a | LC3-Ⅱ/ LC3-Ⅰ | Beclin-1 |
---|---|---|---|---|
Control组 | 0.79±0.04 | 0.86±0.06 | 2.12±0.18 | 0.56±0.04 |
Model组 | 0.25±0.02a | 0.32±0.04a | 0.56±0.06a | 0.10±0.01a |
NOB-L组 | 0.46±0.05b | 0.50±0.02b | 1.08±0.04b | 0.23±0.02b |
NOB-H组 | 0.62±0.03bc | 0.71±0.05bc | 1.83±0.07bc | 0.42±0.02bc |
NOB-H+EX527组 | 0.49±0.03d | 0.53±0.03d | 1.14±0.05d | 0.30±0.02d |
F | 390.386** | 306.840** | 226.787** | 793.818** |
[1] | KELLUM J A, ROMAGNANI P, ASHUNTANTANG G, et al. Acute kidney injury[J]. Nat Rev Dis Primers, 2021, 7(1):52. doi:10.1038/s41572-021-00284-z. |
[2] | RONCO C, BELLOMO R, KELLUM J A. Acute kidney injury[J]. Lancet, 2019, 394(10212):1949-1964. doi:10.1016/S0140-6736(19)32563-2. |
[3] | LEVEY A S, JAMES M T. Acute kidney injury[J]. Ann Intern Med, 2017, 167(9):ITC66-ITC80. doi:10.7326/AITC201711070. |
[4] | WANG S W, XU Y, WENG Y Y, et al. Astilbin ameliorates cisplatin-induced nephrotoxicity through reducing oxidative stress and inflammation[J]. Food Chem Toxicol, 2018, 114:227-236. |
[5] | PICKKERS P, OSTERMANN M, JOANNIDIS M, et al. The intensive care medicine agenda on acute kidney injury[J]. Intensive Care Med, 2017, 43(9):1198-1209. doi:10.1007/s00134-017-4687-2. |
[6] | HOLDITCH S J, BROWN C N, LOMBARDI A M, et al. Recent advances in models,mechanisms,biomarkers,and interventions in cisplatin-induced acute kidney injury[J]. Int J Mol Sci, 2019, 20(12):3011. doi:10.3390/ijms20123011. |
[7] | JAYAKUMAR T, LIN K C, LU W J, et al. Nobiletin,a citrus flavonoid,activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms[J]. Int J Mol Med, 2017, 39(1):174-182. doi:10.3892/ijmm.2016.2822. |
[8] | 武俊紫, 姚政, 熊光轶, 等. 川陈皮素对糖尿病肾病大鼠的作用研究[J]. 中华中医药学刊, 2020, 38(8):117-121,270. |
WU J Z, YAO Z, XIONG G Y, et al. Effect of nobiletin on diabetic nephropathy rats[J]. Chinese Archives of Traditional Chinese Medicine, 2020, 38(8):117-121,270. doi:10.13193/j.issn.1673-7717.2020.08.029. | |
[9] | 胡彦, 王锁刚, 翟琼瑶, 等. 积雪草苷调控SIRT1-FOXO3-PINK1-Parkin通路介导的线粒体自噬保护肾缺血再灌注损伤的机制研究[J]. 天津医药, 2021, 49(11):1148-1153. |
HU Y, WANG S G, ZHAI Q Y, et al. The study of asiaticoside regulating SIRT1-FOXO3-PINK1-Parkin pathway-mediated protective mechanism of mitochondrial autophagy on renal ischemia-reperfusion injury[J]. Tianjin Med J, 2021, 49(11):1148-1153. doi:10.11958/20210354. | |
[10] | 魏桂梅, 任锟, 赵璐, 等. 薯蓣皂苷通过调控SIRT1-FoxO1-自噬通路减轻糖尿病大鼠胰岛素抵抗[J]. 中国病理生理杂志, 2022, 38(2):303-310. |
WEI G M, REN K, ZHAO L, et al. Dioscin attenuates insulin resistance in diabetic rats by regulating SIRT1-FoxO1-autophagy signaling pathway[J]. Chinese Journal of Pathophysiology, 2022, 38(2):303-310. doi:10.3969/j.issn.1000-4718.2022.02.014. | |
[11] | FURUICHI K, WADA T, IWATA Y, et al. Administration of FR167653,a new anti-inflammatory compound,prevents renal ischaemia/reperfusion injury in mice[J]. Nephrol Dial Transplant, 2002, 17(3):399-407. doi:10.1093/ndt/17.3.399. |
[12] | FAULHABER-WALTER R, SCHOLZ S, HALLER H, et al. Health status,renal function,and quality of life after multiorgan failure and acute kidney injury requiring renal replacement therapy[J]. Int J Nephrol Renovasc Dis, 2016, 9:119-128. doi:10.2147/IJNRD.S89128. |
[13] | ROY J P, DEVARAJAN P. Acute kidney injury:Diagnosis and management[J]. Indian J Pediatr, 2020, 87(8):600-607. doi:10.1007/s12098-019-03096-y. |
[14] | 郑德冲. 川陈皮素通过改善自噬流逆转大鼠急性心肌梗死后心室重构的机制研究[D]. 广州: 广州医科大学, 2018. |
ZHENG D C. Nobiletin attenuates adverse cardiac remodeling after acutemyocardial infarction inrats via restoring autophagy flux[D]. Guangzhou: Guangzhou Medical University, 2018. doi:10.7666/d.D01553006. | |
[15] | 杨榆青, 陈滟, 陈学秋, 等. TGF-β/Smads信号通路在川陈皮素治疗糖尿病肾病大鼠中的变化特点研究[J]. 长春中医药大学学报, 2020, 36(4):666-669. |
YANG Y Q, CHEN Y, CHEN X Q, et al. Study on the changes of TGF-β/smads signaling pathway in the treatment of diabetic nephropathy rats with nobiletin[J]. Journal of Changchun University of Chinese Medicine, 2020, 36(4):666-669. doi:10.13463/j.cnki.cczyy.2020.04.017. | |
[16] | MALIK S, BHATIA J, SUCHAL K, et al. Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant,anti-inflammatory and anti-apoptotic effects[J]. Exp Toxicol Pathol, 2015, 67(7/8):427-433. doi:10.1016/j.etp.2015.04.008. |
[17] | WU Y, YAO Y M, LU Z Q. Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure[J]. J Mol Med (Berl), 2019, 97(4):451-462. doi:10.1007/s00109-019-01756-2. |
[18] | DIKIC I, ELAZAR Z. Mechanism and medical implications of mammalian autophagy[J]. Nat Rev Mol Cell Biol, 2018, 19(6):349-364. doi:10.1038/s41580-018-0003-4. |
[19] | CUI J, BAI X, CHEN X. Autophagy and acute kidney injury[J]. Adv Exp Med Biol, 2020, 1207:469-480. doi:10.1007/978-981-15-4272-5_34. |
[20] | 张驰昊, 郑迪, 张成, 等. 虾青素通过上调PINK1/parkin通路增强线粒体自噬并减轻大鼠对比剂急性肾损伤[J]. 中国病理生理杂志, 2022, 38(8):1430-1439. |
ZHANG C H, ZHENG D, ZHANG C, et al. Astaxanthin enhances mitophagy through PINK1/parkin pathway to attenuate contrast-induced acute kidney injury in rats[J]. Chinese Journal of Pathophysiology, 2022, 38(8):1430-1439. | |
[21] | 李燕菊, 冯杰, 赵婷, 等. 水飞蓟素通过调控AMPK/SIRT1途径促进自噬并抑制凋亡减轻大鼠急性肾损伤[J]. 中国中西医结合肾病杂志, 2022, 23(1):11-15,96-97. |
LI Y J, FENG J, ZHAO T, et al. Silymarin promotes autophagy and inhibits apoptosis by regulating AMPK/SIRT1 pathway to reduce acute kidney injury in rats[J]. Chinese Journal of Integrated Traditional and Western Nephrology, 2022, 23(1):11-15,96-97. doi:10.3969/j.issn.1009-587X.2022.01.004. | |
[22] | 米健国, 乔荣勤, 刘少津. 补肾健脾活血方干预骨质疏松模型大鼠骨代谢、氧化应激及自噬的变化[J]. 中国组织工程研究, 2022, 26(26):4147-4152. |
MI J G, QIAO R Q, LIU S J. Bushen Jianpi Huoxue Recipe improves bone metabolism,oxidative stress, and autophagy in osteoporotic rats[J]. Chinese Journal of Tissue Engineering Research, 2022, 26(26):4147-4152. | |
[23] | ZOU Z, LIU B, ZENG L, et al. Cx43 inhibition attenuates sepsis-induced intestinal injury via downregulating ROS transfer and the activation of the JNK1/Sirt1/FoxO3a signaling pathway[J]. Mediators Inflamm, 2019, 2019:7854389. doi:10.1155/2019/7854389. |
[24] | LIU N, CHEN J, GAO D, et al. Astaxanthin attenuates contrast agent-induced acute kidney injury in vitro and in vivo via the regulation of SIRT1/FOXO3a expression[J]. Int Urol Nephrol, 2018, 50(6):1171-1180. doi:10.1007/s11255-018-1788-y. |
[25] | DUSABIMANA T, KIM S R, KIM H J, et al. Nobiletin ameliorates hepatic ischemia and reperfusion injury through the activation of SIRT-1/FOXO3a-mediated autophagy and mitochondrial biogenesis[J]. Exp Mol Med, 2019, 51(4):1-16. doi:10.1038/s12276-019-0245-z. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||